UChicago Medicine

https://www.uchicagomedicine.org/

 

UChicago Medicine
Avatar

Neoadjuvant & Adjuvant Therapy for HER2+, High-Risk, Early Stage BC

By UChicago Medicine FEATURING Rita Nanda
By UChicago Medicine FEATURING Rita Nanda
127 views
March 1, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
First Annual University of Chicago Multidisciplinary Breast Cancer Symposium
07:49
UChicago Medicine

Antibody Drug Conjugates: Overview and Background of a Revolution in…

Feat. H. Rugo
12:13
UChicago Medicine

Trastuzumab Deruxtecan in HER2+ mBC

Feat. H. Rugo
22:01
UChicago Medicine

2024 Updates on ADCs in HER2-Low, HR+, and TNBC

Feat. H. Rugo
12:49
UChicago Medicine

ADCs in Breast Cancer: Ongoing Trials and Future Directions

Feat. H. Rugo
07:52
UChicago Medicine

New and Emerging CDK4/6i Therapies for Advanced HR+ BC

Feat. N. Chen
09:17
UChicago Medicine

Advanced HR+ BC: Elacestrant vs. ET, Alpelisib/Inavolisib for PIK3CA…

Feat. N. Chen
09:01
UChicago Medicine

Advanced ER+ BC: Novel Endocrine Agents Such as ER PROTACs and ER CE…

Feat. N. Chen
20:56
UChicago Medicine

2024 (Neo)Adjuvant Systemic Therapy Updates for HR+ BC

Feat. G. Fleming
05:59
UChicago Medicine

2024 Neoadjuvant IO Updates for HR+ BC

Feat. G. Fleming
09:59
UChicago Medicine

Neoadjuvant & Adjuvant Therapy for HER2+, High-Risk, Early Stage…

Feat. R. Nanda
17:57
UChicago Medicine

Neoadjuvant & Adjuvant Therapy for High-Risk, Early Stage TNBC

Feat. R. Nanda
04:36
UChicago Medicine

Expert Panel Challenging Case Discussion: 60 y/o Female With a Palpa…

Feat. S. Shubeck, S. Chmura, F. Howard, O. Hahn, S. Hanson